Stock A043090 THE TECHNOLOGY CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights The Technology Co.,Ltd.

Equities

A043090

KR7043090000

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-02 pm EDT 		5-day change 1st Jan Change
465 KRW +1.09% Intraday chart for The Technology Co.,Ltd. -2.31% -27.34%
Mar. 22 PangSky Corp. announced that it has received KRW 1 billion in funding from Exergy21 Co., Ltd. CI
Mar. 21 PangSky Corp. announced that it expects to receive KRW 1 billion in funding from Exergy21 Co., Ltd. CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Exergy21 Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Hanchang Corporation entered into an agreement to acquire 73.98% for KRW 25 billion.
CI
An undisclosed buyer agreed to acquire 8.6% stake in Hanchang Biotech Co., Ltd. from Hanchang Corporation for KRW 6.8 billion.
CI
Hanchang Biotech Co., Ltd. acquired 5.61% stake in Hanju Chemical Company Ltd for KRW 2.7 billion.
CI
Ariel Partners Co., Ltd. cancelled the acquisition of 6.54% stake in PharmswellBio Co., Ltd. from Diorpharm Co., Ltd. and Youngjin Jang.
CI
Ariel Partners Co., Ltd. signed a contract to acquire 6.54% stake in PharmswellBio Co., Ltd. from Diorpharm Co., Ltd. and Youngjin Jang for KRW 8 billion.
CI
Wings Group Co., Ltd. cancelled the acquisition of 9.87% stake in PharmswellBio Co., Ltd. from IBDT Co., Ltd.
CI
Diorpharm Co., Ltd. acquired 9.9% stake in PharmswellBio Co., Ltd. from IBDT Co., Ltd. for KRW 6.8 billion.
CI
Diorpharm Co., Ltd. completed the acquisition of 11.4% stake in PharmswellBio Co., Ltd. from Service-In Co., Ltd.
CI
Wings Group Co., Ltd. signed a contract to acquire PharmswellBio Co., Ltd. 9.87% stake in PharmswellBio Co., Ltd. from IBDT Co., Ltd. for KRW 6.8 billion.
CI
Wings Group Co., Ltd. signed a contract to acquire 11.37% stake in PharmswellBio Co., Ltd. from Merit-In for KRW 11 billion.
CI
IBDT Co., Ltd. acquired 9.5% stake in PharmswellBio Co., Ltd. from Service-In Co., Ltd for KRW 7.4 billion.
CI
Service-In Co., Ltd completed the acquisition of 21.82% stake in PharmswellBio Co., Ltd. from Young-Jin Kwon, So-Young Kwon, Yoon-Tae Kwon, Soon-E Kim and Kyung-Sook Kwon.
CI
Service-In Co., Ltd signed a contract to acquire 21.82% stake in PharmswellBio Co., Ltd. from Young-Jin Kwon, So-Young Kwon, Yoon-Tae Kwon, Soon-E Kim and Kyung-Sook Kwon for KRW 14.8 billion.
CI
Service-In Co., Ltd. cancelled the acquisition of 21.82% stake in PharmswellBio Co., Ltd. from Young-Jin Kwon, So-Young Kwon, Yoon-Tae Kwon, Soon-E Kim and Kyung-Sook Kwon.
CI
Service-In Co., Ltd. agreed to acquire 21.82% stake in PharmswellBio Co., Ltd. from Young-Jin Kwon, So-Young Kwon, Yoon-Tae Kwon, Soon-E Kim and Kyung-Sook Kwon. for KRW 16 billion.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A043090 Stock
  4. News The Technology Co.,Ltd.
  5. Highlights